Clinical Trials Logo

Filter by:
NCT ID: NCT06080269 Recruiting - Clinical trials for Traumatic Brain Injury

To Compare the Effect of Receiving the Technology-based Training Along With the Conventional Therapy to the Conventional Therapy Alone on Executive Functions Among People With Traumatic Brain Injury With Mild to Moderate Cognitive Deficit

Start date: May 25, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effect of receiving the technology-based training along with the conventional therapy to the conventional therapy alone on executive functions among people with traumatic brain injury with mild to moderate cognitive deficit. It aims to answer: - If there is significant improvement in executive function skills among people with traumatic brain injury receiving technology-based training along with conventional therapy when compared to people with traumatic brain injury receiving conventional therapy alone. - To see if the demographic variable has any effect on the cognitive improvement Participants will in the intervention group will be given 45 minutes of extra training session using technology along with their usual rehabilitation session. And Participants in the control group will be receiving the usual rehabilitation sessions. Researchers will compare the changes in the outcome measures between the intervention and control group to see if the technology-based training along with conventional therapy had significant effect on executive skills among people with traumatic brain injury.

NCT ID: NCT06077682 Recruiting - Refractive Errors Clinical Trials

Cycloplegic Refraction in Pediatric Patients With Esotropia

Start date: September 1, 2023
Phase: Phase 4
Study type: Interventional

The primary outcome of this study is to compare cyclopentolate 1% and tropicamide 1% for cycloplegic refractions in pediatric populations with esotropia. This will be a prospective double-blinded randomized clinical trial (RCT), multi-center, with randomized sequencing of cycloplegic agent; each patient received one agent at one visit, and the other agent in the next visit (2 different visits ≥ 1 week apart) within 3 months.

NCT ID: NCT05983497 Recruiting - Compassion Fatigue Clinical Trials

Effect of Self-care Skill Education on the Compassionate Satisfaction and Compassionate Fatigue Among Clinical Nurses Clinical Nurses at HMC

Start date: June 20, 2023
Phase: N/A
Study type: Interventional

The health of our nurses is perhaps the most important consideration for delivering excellent patient care. The passionate approach of nurses can lead to a lot of fatigue and stress among nurses. Their health is perhaps the most important consideration for delivering excellent patient care. Self-care provides nurses with the framework for managing professional burnout, compassion fatigue, and traumatic stress. The aim of this study is to assess the impact of self-care skill educational intervention on increasing compassion satisfaction and reducing compassionate fatigue among clinical nurses. The interactive Self-care skill education will be administrated and evaluated.

NCT ID: NCT05937633 Recruiting - Leadership Clinical Trials

Effect of Transformational Leadership Programme on Unit Charge Nurses Leadership Practices

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

Nurse leaders need to be visionary adapting to the fast-paced environments and influence their followers in achievement of the goals. Transformational leadership is one of the most widely used style of leadership across the disciplines. Transformational leadership has been shown to enhance nurse satisfaction, recruitment, and retention to promote healthy environment. The aim of this study is to assess the impact of an educational programme on the transformational leadership characteristics of charge nurses and their relationship to nurse's work engagement. An interactive transformational leadership programme targeting specific leadership knowledge and skills will be administered and evaluated.

NCT ID: NCT05914779 Recruiting - Clinical trials for Out-Of-Hospital Cardiac Arrest

Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Specific Aim : The specific aim is to conduct a randomized prospective clinical trial to determine whether no antibiotics in OHCA patients in the ED with very low likelihood of infection is non-inferior to early antibiotic treatment. Hypothesis a: 28-day all-cause mortality will be non-inferior in OHCA patients with very low likelihood of infection who do not receive antibiotic therapy compared with those who receive early antibiotic therapy Hypothesis b: There will be no difference in subsequent incidence of proven infections in the no antibiotics vs, early antibiotics groups Hypothesis c: There will be no difference in the length of ICU stay and overall hospital stay in the early antibiotics vs. no antibiotics groups

NCT ID: NCT05903950 Recruiting - Metabolic Syndrome Clinical Trials

Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

APCIQ-BP
Start date: June 2024
Phase: N/A
Study type: Interventional

The main objective is to determine if in-home portable air cleaners provide persistent reductions in PM2.5 exposures and improvements in systolic blood pressure and biochemical parameters over 4-weeks in patients with metabolic syndrome residing in Qatar.

NCT ID: NCT05829577 Recruiting - Clinical trials for Autism Spectrum Disorder

Integrated Life Skill Training and Executive Function Strategies in Children With ASD

ASD
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test if using what is called executive function strategies like strategies for improving self-regulation ,strategies for improving planning and problem solving work well when applied within occupational therapy treatment program for children who is diagnosed with Autism Spectrum Disorder , the study will compare between applying regular occupational therapy alone and applying regular occupational therapy plus executive function strategies in improving children with autism spectrum disorder , they will be two group in the study: first group called control group and second group called intervention group, if child is assign on control group he/she will receive regular individual occupational therapy services in autism program which is :Sensory integration which might include things like playing with different interactive games, different textures swinging, bouncing or climbing , and children will also receive life skill training which target training child on self-care skill like grooming, feeding, dressing undressing and toiling skills ) And (if the child assigned on intervention group he/she will receive also regular individual occupational therapy services which described above plus getting executive function training which will be implemented during training the child on daily life skill and this might include using timer during the training, organized schedules, special motivation system and others ,before enrolling children on treatment or control group parent will be asked to sign consent form and after that children will screened based on specific criteria make sure that they are fit for the study then if they meet the study criteria they will also "randomized" into one of two study groups ,Randomization means that putting child into a group by chance. It is like flipping a coin and each child will have a 50% chance of being place in a specific group, following that children will be have detailed assessments which will be done by an experienced occupational therapist and these assessment is aiming to measure the improvement on children condition after receiving therapy ,and will done before treatment , after seven weeks of treatment and completion program at 14 week then data from assessment will be analyzed, each group will receive forty five min regular weekly individual therapy sessions and this extent for thirteen weeks .

NCT ID: NCT05734287 Recruiting - Clinical trials for PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study

Start date: June 28, 2024
Phase:
Study type: Observational [Patient Registry]

This mixed cohort study will test the frequency of PCOS among young females presenting with one of the clinical hyperandrogenism criteria: acne, hirsutism and/or hair loss. Diagnosis will be based on the recent PCOS clinical, biochemical and biophysical criteria recently published " International evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) 2018".

NCT ID: NCT05730907 Recruiting - Cardiogenic Shock Clinical Trials

Efficacy and Clinical Outcomes of Levosimendan in E-CPR

ECPR
Start date: February 20, 2023
Phase:
Study type: Observational

Treatment of refractory cardiac arrest requiring cardiopulmonary resuscitation (CPR) may be augmented with Extracorporeal membrane oxygenation (ECMO) to re-establish perfusion in the absence of return of spontaneous circulation. Literature has demonstrated that ECMO initiated during advanced cardiopulmonary life support may confer superior survival rates with acceptable survival and a relatively low incidence of significant neurologic impairment. Levosimendan has not been investigated in patients with cardiac arrest who underwent Extracorporeal CPR (E-CPR). The current study aims to examine whether levosimendan use in the aforementioned patient population could improve survival and ECMO parameters.

NCT ID: NCT05730894 Recruiting - Morality Clinical Trials

Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation.

ECMO
Start date: February 28, 2023
Phase:
Study type: Observational

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) support is a lifesaving tool used to treat cardiogenic shock, acute heart failure, or extracorporeal cardiopulmonary resuscitation(CPR). However, its use is associated with significant complications, including mortality. We aim to conduct a retrospective observational study of all patients at Heart Hospital who required VA-ECMO support due to cardiogenic shock during 1/06/2016 and 1/06/2022 to report the incidence of in-hospital mortality among patients who required VA-ECMO along with the predictors of mortality. Data will be collected to identify baseline characteristics and outcomes including clinical variables predictive of poor outcomes.